TransPharma Medical Ltd.
TransPharma Announces Successful Completion of Phase 2 Trial of ViaDerm-hPTH 1-34 in Postmenopausal Women with Osteoporosis
Published in Lab Business Week, September 20th, 2009
In June 2008, Eli Lilly and Company and TransPharma entered a licensing and development agreement relating to TransPharma's ViaDerm-hPTH(1-34) product for the treatment of severe osteoporosis. As part of this project, TransPharma has completed a three-month Phase 2A trial for transdermal PTH(1-34). The primary and secondary endpoints...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2009-09-20)
More Articles from Lab Business Week
- Applied NeuroSolutions, Inc.
Applied NeuroSolutions Appoints Craig Taylor as President & CEO - Bio-Reference Laboratories, Inc.
Bio-Reference Laboratories, Inc. Announces Continued Strong Growth Across All Laboratory Divisions - Biopharmaceuticals
Affitech Appoints Dr Robert Burns as CEO and Dr Alexander Duncan as SVP Research & Development - BrainStorm Cell Therapeutics, Inc.
Prof. Offen to Discuss Latest Progress of Brainstorm Today on Israeli National Radio - Clinical and Laboratory Standards Institute CLSI
CLSI Publishes Guideline and Supplement for Antifungal Disk Diffusion Susceptibility Testing of Yeasts - Digital Pathology Association
Digital Pathology Association to Host Fifth Annual Pathology Visions Conference - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
